CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-08-16 | Papanek Julie Director | Conversion | +1,869,922 | 1,869,922 | ||
| 2016-08-16 | Papanek Julie Director | Purchase | +583,333 | $12.00 | $7.0M | 2,453,255 |
| 2016-08-16 | Papanek Julie Director | Conversion · Series C Preferred Stock | −27,113,877 | 0 | ||
| 2016-08-16 | CANAAN X L.P. Director | Conversion | +1,869,922 | 1,869,922 | ||
| 2016-08-16 | CANAAN X L.P. Director | Purchase | +583,333 | $12.00 | $7.0M | 2,453,255 |
| 2016-08-16 | CANAAN X L.P. Director | Conversion · Series C Preferred Stock | −27,113,877 | 0 | ||
| 2016-08-16 | Shanafelt Armen Director | Conversion | +206,896 | 206,896 | ||
| 2016-08-16 | Shanafelt Armen Director | Conversion | +630,541 | 837,437 | ||
| 2016-08-16 | Shanafelt Armen Director | Conversion | +678,712 | 1,516,149 | ||
| 2016-08-16 | Shanafelt Armen Director | Purchase | +583,333 | $12.00 | $7.0M | 2,099,482 |
| 2016-08-16 | Shanafelt Armen Director | Conversion · Series A Preferred Stock | −3,000,000 | 0 | ||
| 2016-08-16 | Shanafelt Armen Director | Conversion · Series B Preferred Stock | −9,142,857 | 0 | ||
| 2016-08-16 | Shanafelt Armen Director | Conversion · Series C Preferred Stock | −9,841,333 | 0 | ||
| 2016-08-16 | LV Management Group, LLC 10% owner | Conversion | +206,896 | 206,896 | ||
| 2016-08-16 | LV Management Group, LLC 10% owner | Conversion | +630,541 | 837,437 | ||
| 2016-08-16 | LV Management Group, LLC 10% owner | Conversion | +678,712 | 1,516,149 | ||
| 2016-08-16 | LV Management Group, LLC 10% owner | Purchase | +583,333 | $12.00 | $7.0M | 2,099,482 |
| 2016-08-16 | LV Management Group, LLC 10% owner | Conversion · Series A Preferred Stock | −3,000,000 | 0 | ||
| 2016-08-16 | LV Management Group, LLC 10% owner | Conversion · Series B Preferred Stock | −9,142,857 | 0 | ||
| 2016-08-16 | LV Management Group, LLC 10% owner | Conversion · Series C Preferred Stock | −9,841,333 | 0 |
Page 29 of 29 · 580 trades